Navigation Links
New Clinical Study News for Treatment of Sinusitis, Sinus Infection and Allergy Sufferers Now Have a New Effective Form of Relief through Sinus Dynamics

This exciting clinical study news is the best news that we have been waiting on for the past four years to prove the deposition of the medication through Sinus Dynamics.

WESTLAKE VILLAGE, Calif., March 23 /PRNewswire/ -- Most ENTs and physicians who have prescribed Sinus Dynamics have always asked if it would be better to have a clinical study done on the amount of medication deposited and penetrated into the sinuses. Now this fantastic news and clinical study proves the SINUS DYNAMICS treatment to be 82.9% successful for treatment of pre-sinus surgery, post-sinus surgery, acute and chronic sinusitis.

I encourage everyone to please spend a few minutes to read the attached study and familiarize yourself with the facts in the study. After reading the study, I am sure you will be able to better understand why Sinus Dynamics treatment is very effective treatment compared to any other treatments (Sinus Wash, Sinus Spray, oral Antibiotics and medications) for sinusitis. Now you can share this great news with everyone who has sinusitis or sinus infections and needs fast and proven treatment to overcome their sinusitis and sinus infection problems for good.

As you read this study, it will show you that Sinus Dynamics has the smallest particle size in the industry and is able to deposit the medicine into the sinuses better than any other sinusitis or sinus infection products without any side effects. Also in order to have the best result in TOPICAL treatment of sinusitis, you need to have the particle size of 3.2 mmhg and Sinus Dynamics is the ONLY treatment that meets this requirement.

The comprehensive study was published in August of 2008 and was conducted by clinical research physicians who are on staff with three prominent American medical universities. When compared to any other aerosolized therapies available in the medical industry, the study fully confirms that the smaller size of the mist particle of the Sinus Dynamics SinusAero Nebulizer penetrates the ostium for achieving topical deposition of medications on the mucosa of the paranasal sinus cavities; including the hard-to-reach maxillary sinus. Additionally, the study discusses the fact that the deposition of the medication on the sinus lining was the same whether or not the patient had a FESS procedure (FESS stands for Functional Endoscopic Sinus Surgery). The study also discussed that the rate of recovery from the patient's acute or chronic sinusitis was the same using the Sinus Dynamics therapy for patients who had FESS procedures performed on them, and for those who did not. Please see the last paragraph on page one of the study where Sinus Dynamics is mentioned.

The Sinus Dynamics program is a unique form of treatment.

Please check the testimonials on

Sinus Dynamics works with most insurance companies and will handle the prescription from when it is received through handling all insurance relations. Select antibiotics, anti-fungals and anti-inflammatories are also offered to help relieve patients of their symptoms of sinusitis and allergies. Sinus Dynamics can be visited on the web at or reached toll free at 877-447-4276.

This press release was issued through For further information, visit

SOURCE Sinus Dynamics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Herbalife Protein Shake Proven Effective in Clinical Study
2. Latest Osteoporosis Research Translated for Health Professionals to Use in Clinical Setting
3. Former Merck Executive Joins Board of Clinical Information Network, Inc.
4. New Clinical Study News for Treatment of Sinusitis - Sinus Infection and Allergy Suffers Now Have a New Effective Form of Relief through Sinus Dynamics
5. Conflicts of interest in clinical research
6. Smart Phones to be used by assisTek to Collect Patient-Reported Outcomes in a Large Multinational Clinical Trial
7. Clinical Data from Plastic Surgeon in New Jersey Helped in Final Determination of 2008's Top Plastic Surgery Procedures
8. EAU launches new clinical guidelines for 2009 -- kidney cancer
9. New Clinical Study Finds Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Accurate in the Noninvasive Monitoring of Fluid Status During Surgery
10. Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings
11. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress
Post Your Comments:
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology: